SEC Tracker
Get the app

Milestone Pharmaceuticals MIST

Milestone Pharmaceuticals: reports an executive or board change and reports shareholder vote results

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 10.3
Material contract
  • Reports an executive or board change (5.02)
  • Reports shareholder vote results (5.07)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Milestone Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Assembly Biosciences ASMB public float $98M, Jun 30, 2025
  2. DiaMedica Therapeutics DMAC public float $96M, Jun 30, 2025
  3. Ironwood Pharmaceuticals IRWD public float $103M, Jun 30, 2025
  4. Vaxart VXRT public float $103M, Jun 30, 2025
  5. Larimar Therapeutics LRMR public float $95M, Jun 30, 2025